Scientists from Tennessee recently said a drug they have been developing could treat radiation sickness, and they are working to raise the money to fulfill the last stage of requirements from the Food and Drug Administration (FDA).
Currently, there is no drug available to treat gastrointestinal radiation sickness, but a team of University of Tennessee researchers led by cell biologist and cancer researcher Dr. Gabor Tigyi and Professor Leonard Johnson said they are working on a drug that shows potential.
People develop radiation sickness after receiving a large dose of radiation over a short period of time, with the amount of radiation absorbed by the body determining the degree of illness, according to the Mayo Clinic. The disease is also known as Acute Radiation Syndrome (ARS) or radiation poisoning and can cause diarrhea, nausea and fatigue, with high levels of radiation fallout leading to death, often within a couple of weeks.
Since the first atomic bombings at the end of World War II, radiation sickness has largely been linked to accidents at nuclear power plants, such as the 1986 fire and explosion at the Chernobyl nuclear plant in Ukraine.
With the war in Ukraine escalating, a number of news outlets have reported that European and U.S. consumers were panic buying iodine and potassium iodide tablets in response to Russian President Vladimir Putin's threats to use nuclear weapons as his war with Ukraine extended into its second month.
Potassium iodide is absorbed by the thyroid gland. The right dose can saturate the thyroid gland, helping to block the radioactive iodine that is released by radiation fallout. However, according to the American Council on Science and Health, the compound is only effective at blocking one radiation-related illnessthyroid cancer. By contrast, until recently there have been no effective treatments for parts of the body, including the gastrointestinal tract, which are especially vulnerable to radiation exposure.
The team led by Tigyi and Johnson has focused their work on the gastrointestinal tract and on the body's mechanism for repairing the damage caused by high-energy radiation.
Radiation exposure affects the human body's main molecules, DNA, proteins, lipids and sugars, but the body has a highly efficient DNA damage repair mechanism, which is capable of protecting against changes in our DNA, Tigyi told Newsweek. His team has spent two decades investigating lysophosphatidic acid (LPA), which acts as a natural protective molecule in cells. The researchers discovered that LPA has the ability to boost DNA damage repair and cell regeneration pathways after exposure to radiation.
Yet when the LPA system is hijacked in aggressive tumor stem-like cells, this mechanism can also help cancer cells resist radiation-therapy induced cell death.
The drug that the team has developed, RX-100, aims to use both the beneficial and destructive tendencies of LPA, Tigyi says.
"The drug discovery efforts we have been undertaking are targeting at both sides," he added. "To exploit LPA-based drugs that humans can benefit from and other drugs to hit the cancer stem-cells on the head and prevent them from being able to use LPA for generating resistance, invasion, and evasion of tumor immunity."
The target of RX-100 is intestinal stem cells, which regenerate the intestinal lining, but can be hard to replace because of their location at the bottom of the gut. However, the drug candidates they have developed, when administered via a single jab, can reach these intestinal stem cells, protect them and promote the regeneration of the gut.
In addition to treating ARS, the drug has the potential to be used to combat other illnesses, Tigyi said, including blocking the toxin-inducing process responsible for the development of diarrhea in cholera. It also has the potential to fight clostridium difficile, a severe bacterial infection, by strengthening the gut barrier function.
RxBio Inc., the company that Tigyi founded, has already tested the drug's efficacy in rodents, but must show that it is safe and effective in an additional animal species, as trials using radiation can not include human beings. For this stage, the company is looking to raise around $170 million of additional funding.
Read the original post:
What Is Radiation Sickness and Are There Drugs to Treat It? - Newsweek
- I took an international trip with my frozen eggs to learn about the fertility industry - MIT Technology Review - September 16th, 2022
- GM begins US Ultium battery production for Hummer EV in Ohio amidst union pushback - Electrek.co - September 8th, 2022
- On the scent: ETSU researchers exploring treatments for loss of smell - East Tennessee State University - September 8th, 2022
- University of Minnesota researcher seeks to sustain Alzheimer's findings amid image scandal - Star Tribune - August 5th, 2022
- Men Share The Costly Lengths They've Taken To Prevent Balding - HuffPost - July 11th, 2022
- The end of Roe v. Wade affects more than just abortion - Vox.com - July 3rd, 2022
- IMAC Holdings, Inc. Announces Initiation of Third and Final Cohort of its Phase 1 Clinical Study of Umbilical Cord-Derived Mesenchymal Stem Cells for... - March 25th, 2022
- Roslin Tech in multi-million bid to fund sustainable food - HeraldScotland - August 31st, 2021
- What Is DiscGenics, The Company Christopher Duntsch Helped Found, And Where Is It Today? - Oxygen - July 21st, 2021
- Karen Hasty Named Among 2021 Super Women In Business by Memphis Business Journal - UTHSC News - June 6th, 2021
- GM pledges to be carbon neutral by 2040; Dingell applauds efforts - Dearborn Press and Guide - February 16th, 2021
- Former NFL star Eddie George returns to Vero Beach for therapy, this time on shoulder - TCPalm - September 22nd, 2020
- US Performing Hysterectomies On Immigrants? - The Shadow League - September 22nd, 2020
- Sunway University's Collaboration with Harvard Medical School Makes Advances in Potential Cancer Treatment using Gene Therapy - Yahoo Finance - August 26th, 2020
- Non-Profit Offers Free Stem Cell Therapy to Veterans - Pain News Network - March 28th, 2020
- CAR T Cells to Go? Outpatient Therapy Can Be Safe - Medscape - March 1st, 2020
- Breakthrough, Non-Invasive Treatment Called Axol Therapy For Erectile Dysfunction And Enhanced Sexual Performance Now Available At Colorado Urology -... - March 1st, 2020
- Alberta baby Mighty Hudson home after gene therapy: hes cured - Global News - January 24th, 2020
- Year in Review: The Top Science Stories of 2019 - WTTW News - January 5th, 2020
- Early Results Are Positive for Experimental CRISPR Therapies - The Scientist - November 22nd, 2019
- Towards a universal flu vaccine - Scientific American - September 23rd, 2019
- What We Do Stem Cell Institute of Middle Tennessee - March 20th, 2019
- UTHSC | Department of Ophthalmology | Hamilton Eye Institute - March 7th, 2019
- Stem Cell Treatment Nashville TN - Precision Pain Care - January 15th, 2019
- Equine Regenerative Medicine - University of Tennessee system - September 15th, 2018
- Lung Institute | Stem Cell Treatment Tennessee - September 25th, 2017
- EPS for BioLife Solutions (BLFS) Expected At $-0.06; Last Week Dean Foods Co (DF) Coverage - Herald KS - July 30th, 2017
- Stem Cell Therapy Franklin TN | Stem Cell Treatment - July 7th, 2017
- When C9ORF72 Silences U2, Spliceosomes Can't Find What They're Looking For - Alzforum - July 7th, 2017
- Knoxville TN Stem Cell Treatment | Knoxville Tennessee ... - November 23rd, 2016
- Lung Institute | Stem Cell Treatment Center in TN for Lung ... - November 9th, 2016
- The Stem Cell Transplant Process - Covenant Health - May 12th, 2015
- SpringerPlus | Full text | What makes cancer stem cell ... - April 27th, 2015
- Pros And Cons Of Stem Cell Research - Popular Issues ... - January 29th, 2015
- Chattanoogan.com - Chattanooga's source for breaking local news - November 26th, 2014
- Stem Cell Transplants in Dogs | eHow - eHow | How to ... - November 19th, 2014
- Memphis Tennessee Stem Cell Research | Memphis TN Stem ... - November 11th, 2014
- Human stem cell research - Religious Tolerance - September 27th, 2014
- Stem Cells Macular DegenerationStem Cell Treatments - September 27th, 2014
- Understanding Stem Cell Transplant VICC Momentum - September 27th, 2014
- Tennessee in middle of embryonic stem cell fight | wbir.com - August 26th, 2014
- Stem Cell Transplant Program - Covenant Health - August 23rd, 2014
- Tennessee Stem Cell Therapy | Stem Cell Treatments - August 22nd, 2014